Advanced search
Publication Cover
Leukemia & Lymphoma Volume 65, 2024 - Issue 1
Submit an article Journal homepage
206
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Cutaneous lymphoproliferative disorders after COVID-19 vaccination: clinical presentation, histopathology, and outcomes

Emily R. Gordona Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USAView further author information
,
Bradley D. Kwintab Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USAView further author information
,
Celine M. Schreidaha Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USAView further author information
,
Lauren M. Fahmya Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USAView further author information
,
Oluwaseyi Adeuyana Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USAView further author information
,
Dawn Queenb Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USAView further author information
,
Megan H. Tragerb Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USAView further author information
,
Cynthia M. Magroc Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USAView further author information
&
Larisa J. Geskinb Department of Dermatology, Columbia University Irving Medical Center, New York, NY, USACorrespondence[email protected]
View further author information
 show all
Pages 48-54 | Received 27 Jul 2023, Accepted 08 Oct 2023, Published online: 20 Oct 2023

References

  • McMahon DE, Amerson E, Rosenbach M, et al. Cutaneous reactions reported after moderna and pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol. 2021;85(1):46–55. doi:10.1016/j.jaad.2021.03.092
  • LeWitt T, Chung C, Manton J, et al. Rare lymphomatoid reactions following SARS-CoV-2 vaccination. JAAD Case Rep. 2022;20:26–30. doi:10.1016/j.jdcr.2021.11.021
  • Koumaki D, Marinos L, Nikolaou V, et al. Lymphomatoid papulosis (LyP) after AZD1222 and BNT162b2 COVID ‐19 vaccines. Int J Dermatol. 2022;61(7):900–902. doi:10.1111/ijd.16296
  • Hooper MJ, Veon FL, LeWitt TM, et al. Cutaneous T-cell–rich lymphoid infiltrates after SARS-CoV-2 vaccination. JAMA Dermatol. 2022;158(9):1073–1076. doi:10.1001/jamadermatol.2022.2383
  • Montoya VG, Cardona LG, Morales S, et al. SARSCOV-2 vaccine associated with primary cutaneous peripheral T cell lymphoma. Eur J Cancer. 2022;173: s 32–S33. doi:10.1016/S0959-8049(22)00617-7
  • Revenga-Porcel L, Peñate Y, Granados-Pacheco F. Anaplastic large cell lymphoma at the SARS-CoV2 vaccine injection site. J Eur Acad Dermatol Venereol. 2023;37(1):e32–e34. doi:10.1111/jdv.18615
  • Bresler SC, Menge TD, Tejasvi T, et al. Two cases of challenging cutaneous lymphoid infiltrates presenting in the context of COVID-19 vaccination: a reactive lymphomatoid papulosis-like eruption and a bona fide lymphoma. J Cutan Pathol. 2023;50(3):213–219. doi:10.1111/cup.14371
  • Brumfiel CM, Patel MH, DiCaudo DJ, et al. Recurrence of primary cutaneous CD30-positive lymphoproliferative disorder following COVID-19 vaccination. Leuk Lymphoma. 2021;62(10):2554–2555. doi:10.1080/10428194.2021.1924371
  • Panou E, Nikolaou V, Marinos L, et al. Recurrence of cutaneous T‐cell lymphoma post viral vector COVID‐19 vaccination. J Eur Acad Dermatol Venereol. 2022;36(2):e91–e93. doi:10.1111/jdv.17736
  • Kempf W, Hegyi I, Pfaltz K. O-117 - Cutaneous lymphoproliferations after mRNA vaccination: a clinicopathologic characterization. European Journal of Cancer. 2023;190:113005. doi:10.1016/j.ejca.2023.113005
  • Mathieu E, Ritchie H, Rodés-Guirao L, et al. Coronavirus pandemic (COVID-19). Our World in Data, 2020. https://ourworldindata.org/coronavirus
  • Walsh EE, Frenck RW, Jr, Falsey AR, et al. Safety and immunogenicity of two RNA-based covid-19 vaccine candidates. N Engl J Med. 2020;383(25):2439–2450. doi:10.1056/NEJMoa2027906
  • Jackson LA, Anderson EJ, Rouphael NG, et al. An mRNA vaccine against SARS-CoV-2 - preliminary report. N Engl J Med. 2020;383(20):1920–1931. doi:10.1056/NEJMoa2022483
  • Bettini E, Locci M. SARS-CoV-2 mRNA vaccines: immunological mechanism and beyond. Vaccines (Basel). 2021;9(2):147. Published 2021 Feb 12. doi:10.3390/vaccines9020147
  • Mendonça SA, Lorincz R, Boucher P, et al. Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic. NPJ Vaccines. 2021;6(1):97. doi:10.1038/s41541-021-00356-x
  • Pulitzer M. Cutaneous T-cell lymphoma. Clin Lab Med. 2017;37(3):527–546. doi:10.1016/j.cll.2017.06.006
  • Ansell P, Simpson J, Lightfoot T, et al. Non-Hodgkin lymphoma and autoimmunity: does gender matter? Int J Cancer. 2011;129(2):460–466. doi:10.1002/ijc.25680
  • Fernandez KH, Bream M, Ali MA, et al. Investigation of molluscum contagiosum virus, orf and other parapoxviruses in lymphomatoid papulosis. J Am Acad Dermatol. 2013;68(6):1046–1047. doi:10.1016/j.jaad.2012.12.972
  • Magro C, Crowson AN, Franks L, et al. The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin. Clin Dermatol. 2021;39(6):966–984. Epub 2021 Jul 25. PMID: 34920834; PMCID: PMC8310467. doi:10.1016/j.clindermatol.2021.07.011
  • Thiel J, Kimmig L, Salzer U, et al. Genetic CD21 deficiency is associated with hypogammaglobulinemia. J Allergy Clin Immunol. 2012;129(3):801–810.e6. doi:10.1016/j.jaci.2011.09.027
  • Wright CW, Duckett CS. The aryl hydrocarbon nuclear translocator alters CD30-mediated NF-kappaB-dependent transcription. Science. 2009;323(5911):251–255. doi:10.1126/science.1162818
  • van der Weyden CA, Pileri SA, Feldman AL, et al. Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions. Blood Cancer J. 2017;7(9):e603–e603. doi:10.1038/bcj.2017.85

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.